Page 195 - Read Online
P. 195

Berezin et al. Vessel Plus 2020;4:15  I  http://dx.doi.org/10.20517/2574-1209.2020.03                                                Page 13 of 13

                   Biol 2016;36:525-33.
               85.  Alique M, Ramírez-Carracedo R, Bodega G, Carracedo J, Ramírez R. Senescent Microvesicles: a novel advance in molecular
                   mechanisms of atherosclerotic calcification. Int J Mol Sci 2018;19:E2003.
               86.  Blaser MC, Aikawa E. Roles and regulation of extracellular vesicles in cardiovascular mineral metabolism. Front Cardiovasc Med
                   2018;5:187.
               87.  Paone S, Baxter AA, Hulett MD, Poon IKH. Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the
                   progression of atherosclerosis. Cell Mol Life Sci 2019;76:1093-106.
               88.  Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?
                   Arterioscler Thromb Vasc Biol 2013;33:449-54.
               89.  Zhao Y, Li Y, Luo P, Gao Y, Yang J, et al. XBP1 splicing triggers miR-150 transfer from smooth muscle cells to endothelial cells via
                   extracellular vesicles. Sci Rep 2016;6:28627.
               90.  Yin M, Loyer X, Boulanger CM. Extracellular vesicles as new pharmacological targets to treat atherosclerosis. Eur J Pharmacol
                   2015;763:90-103.
               91.  Togliatto G, Dentelli P, Rosso A, Lombardo G, Gili M, et al. PDGF-BB carried by endothelial cell-derived extracellular vesicles reduces
                   vascular smooth muscle cell apoptosis in diabetes. Diabetes 2018;67:704-16.
               92.  Sanden M, Botha J, Nielsen MRS, Nielsen MH, Schmidt EB, et al. BLTR1 and CD36 expressing microvesicles in atherosclerotic patients
                   and healthy individuals. Front Cardiovasc Med 2018;5:156.
               93.  Pretorius L, Thomson GJA, Adams RCM, Nell TA, Laubscher WA, et al. Platelet activity and hypercoagulation in type 2 diabetes.
                   Cardiovasc Diabetol 2018;17:141.
               94.  Vítková V, Živný J, Janota J. Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes.
                   Biomark Med 2018;12:161-75.
               95.  Shi C, Ulke-Lemée A, Deng J, Batulan Z, O’Brien ER. Characterization of heat shock protein 27 in extracellular vesicles: a potential anti-
                   inflammatory therapy. FASEB J 2019;33:1617-30.
               96.  Jansen F, Li Q, Pfeifer A, Werner N. Endothelial- and immune cell-derived extracellular vesicles in the regulation of cardiovascular health
                   and disease. JACC Basic Transl Sci 2017;2:790-807.
               97.  Hutcheson JD, Aikawa E. Extracellular vesicles in cardiovascular homeostasis and disease. Curr Opin Cardiol 2018;33:290-7.
               98.  Jansen F, Nickenig G, Werner N. Extracellular vesicles in cardiovascular disease: potential applications in diagnosis, prognosis, and
                   epidemiology. Circ Res 2017;120:1649-57.
               99.  Pardo F, Villalobos-Labra R, Sobrevia B, Toledo F, Sobrevia L. Extracellular vesicles in obesity and diabetes mellitus. Mol Aspects Med
                   2018;60:81-91.
               100. Li F, Fang R, Rao L, Meng F, Zhao X. Research progress on exosomes in diagnosis and treatment of cardiovascular diseases. Zhejiang Da
                   Xue Xue Bao Yi Xue Ban 2018;47:320-6. (in Chinese)
               101. Dickhout A, Koenen RR. Extracellular vesicles as biomarkers in cardiovascular disease; chances and risks. Front Cardiovasc Med
                   2018;5:113.
               102. Berezin AE, Kremzer A, Berezina T, Martovitskaya Y. The signature of circulating microparticles in heart failure patients with metabolic
                   syndrome. J Circ Biomark 2016;5:1849454416663659.
               103. Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA. The predictive role of circulating microparticles in patients with
                   chronic heart failure. BBA Clin 2014;3:18-24
               104. Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV. The pattern of circulating microparticles in patients with diabetes mellitus
                   with asymptomatic atherosclerosis. Acta Clin Belg 2016;71:38-45.
               105. Bei Y, Chen T, Banciu DD, Cretoiu D, Xiao J. Circulating exosomes in cardiovascular diseases. Adv Exp Med Biol 2017;998:255-69.
               106. Zamani P, Fereydouni N, Butler AE, Navashenaq JG, Sahebkar A. The therapeutic and diagnostic role of exosomes in cardiovascular
                   diseases. Trends Cardiovasc Med 2019;29:313-23.
               107. Lu M, Yuan S, Li S, Li L, Liu M, et al. The exosome-derived biomarker in atherosclerosis and its clinical application. J Cardiovasc Transl
                   Res 2019;12:68-74.
   190   191   192   193   194   195   196   197   198   199   200